This study aimed to determine the usefulness of the combination of several electrocardiographic markers on risk assessment of ventricular fibrillation (VF) in patients with Brugada syndrome (BrS).
Brugada syndrome (BrS) is a distinct form of idiopathic ventricular fibrillation (VF). BrS is characterized by a unique electrocardiographic pattern consisting of a right bundle branch blocklike morphology and ST-segment elevation in precordial leads. Results of many studies (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) have suggested that patients with syncope, particularly patients with a spontaneous type 1 electrocardiographic pattern, have a significant risk of sudden cardiac death (SCD) or VF.
In the remaining population of asymptomatic subjects, the risk is lower, but not negligible (1, 5) . Therefore, assessment of the risk of SCD and VF in patients with a Brugada-type electrocardiogram (ECG) is clinically important, especially when sporadic cases are detected during routine medical checkups.
Many markers for the development of VF in BrS have been reported, including clinical markers of a family history of SCD (11) , syncope with nonprodromal episodes (12) , episodes of paroxysmal atrial fibrillation (PAF) (13) , electrocardiographic markers of a spontaneous type 1 electrocardiographic pattern, existence of late potential (14) , fragmented QRS (f-QRS) (15) , T-wave alternans after sodium channel blocker injection (16) , an inferolateral early repolarization (ER) pattern (17, 18) , a genetic marker of SCN5A, a gene encoding the cardiac sodium channel (19) , electrophysiological markers of VF inducibility by programmed electrical stimulation, abnormal restitution properties, and ventricular effective refractory period <200 ms (20) . However, the relationship of these markers and the usefulness of their combination have not been sufficiently examined.
In this study, we examined risk markers, with a focus on noninvasive surface electrocardiographic markers categorized by depolarization and repolarization abnormalities, and attempted to improve the accuracy of predicting and classifying high-and low-risk BrS patients.
Methods
Patient population and clinical data collection. We retrospectively analyzed data from 246 consecutive patients (236 men; mean age, 47.6 AE 13.6 years) with a Brugadatype ECG in Okayama University Hospital. All patients showed a typical electrocardiographic Brugada pattern with or without a sodium channel blocker (pilsicainide), which was defined previously (11) . Informed consent was obtained from all patients, and clinical data, including data on age, sex, family history of SCD (younger than 45 years of age), history of syncope episodes, history of VF episodes, and VF induction during an electrophysiological (EP) study were obtained from patient records. Follow-up data defined the start of follow-up as the first visit and the end of follow-up as death, arrhythmic events, or the last visit. Electrocardiographic measurements. Standard 12-lead ECGs were recorded in the same way and were evaluated for the R-R interval, PQ interval, QRS width, QT interval, ST-segment level at the J point, and number of positive spikes within the QRS complex in leads V 1 through V 3 . A spontaneous type 1 pattern was defined as documentation by an ECG of a type 1 pattern in the absence of class I antiarrhythmic drugs. The presence of a late potential was evaluated by a signal-averaged ECG (ART 1200 EPX [Arrhythmia Research Technology, Inc., Fitchburg, Massachusetts], noise level <0.3 mV, and high-pass filtering of 40
Hz with a bidirectional 4-pole Butterworth). A late potential was considered positive when the following 2 criteria were met: root mean square voltage of the terminal 40 ms in the filtered QRS complex of <20 mV and a duration of lowamplitude signals <40 mV in the terminal filtered QRS complex of >38 ms (21) .
The presence of f-QRS was defined as an abnormal fragmentation within the QRS complex as !4 spikes in 1 or !8 spikes in leads V 1 , V 2 , and V 3 , as described previously (15) (Fig. 1A ).
An inferolateral ER pattern was defined as an elevation of the J-point in at least 2 consecutive leads. The amplitude of the J-wave or J-point elevation had to be at least 1 mm above the baseline level, either as QRS slurring or notching in the inferior lead (II, III, and aVF), lateral lead (I, aVL, and V 4 to V 6 ), or both, as described previously (17, 18, (22) (23) (24) (25) ( Fig. 1B) .
We divided the patients into the depolarization abnormality (PQ interval >200 ms, QRS width !120 ms, positive late potential, and f-QRS) group and the repolarization abnormality (QT prolongation and inferolateral ER pattern) group. EP study. After obtaining written informed consent from patients, an EP study was performed as described previously (1, 26) in all patients. The criterion for the induction of ventricular arrhythmia was induction of sustained polymorphic ventricular tachycardia or VF by programmed electrical stimulation from the right ventricular apex, right ventricular outflow tract, or left ventricle with a maximum of 3 extrastimuli at 2 cycle lengths. Gene mutation analysis of SCN5A. This study was performed in compliance with guidelines for human genome studies of the Ethics Committee of Okayama University, as described previously (13) . In brief, all exons of SCN5A were amplified by polymerase chain reaction from DNA isolated from peripheral leukocytes of the patients. Genomic DNA was extracted from peripheral blood leukocytes using a DNA extraction kit (Gentra, Minneapolis, Minnesota) and was stored at À30 C until use. Twenty-seven exons of the SCN5A gene were amplified with previously reported intronic primers (13) . Statistical analysis. Statistical analysis was performed using SPSS 17.0 for Windows (SPSS Inc., Chicago, Illinois). Data are expressed as mean AE SD or median (interquartile range). A Student t test was performed to test for statistical differences between 2 unpaired mean values, and categorical data and percentage frequencies were analyzed by the chi-square test. On univariate analysis, 9 predictors were significantly associated with arrhythmic events. Multivariate analysis using Cox proportional hazards regression analysis estimated those 9 predictors and was performed in search of independent risk factors for arrhythmic events. This analysis was based on a stepwise algorithm, with the p value set at 0.05 for entering and 0.1 for exclusion. The effects of ER and f-QRS on arrhythmic events during the follow-up period were evaluated using the log-rank test and were described using a Kaplan-Meier curve. A p value < 0.05 was considered statistically significant.
Results
Patient characteristics. Baseline patient characteristics are summarized in Table 1 . Sixty-nine patients (28.0%) had a family history of SCD, 40 (16.3%) had history of syncope episodes, and 13 (5.3%) had history of VF episodes. Gene analysis showed that an SCN5A gene mutation was present in 17 patients (13.8%). A spontaneous type 1 ECG pattern was observed in 156 patients (63.4%). In the EP study, VF was induced in 71 patients (45.8%), and 63 of them (25.6%) had received an implantable cardioverter-defibrillator (ICD). During the follow-up period of 45.1 AE 44.3 months, fatal arrhythmic events occurred in 24 patients (23 appropriate ICD shocks caused by VF and 1 cardiac arrest during sleep). Clinical/genetic/electrocardiographic parameters and cardiac events. Clinical and genetic parameters were compared in BrS patients with and without cardiac events during the follow-up period ( Table 2) . PAF episodes (9 of 24, 37.5% vs. 35 of 222, 15.8%, p ¼ 0.013), a history of VF (9 of 24, 37.5% vs. 4 of 222, 1.8%; p < 0.001), a history of syncope episodes (13 of 24, 54.2% vs. 27of 222, 12.2%; p < 0.001), VF inducibility during the EP study (17 of 24, 70.8% vs. 54 of 131, 41.2%; p ¼ 0.007), and spontaneous type 1 ECG pattern (22 of 24, 91.7% vs. 134 of 222, 60.4%; p ¼ 0.002) were observed more often in VF/SCD patients than in those without VF/SCD, but other parameters such as age, sex, family history of SCD, and SCN5A gene mutation were not different.
Among the electrocardiographic parameters of depolarization abnormalities, QRS width !120 ms (8 of 24, 33.3% vs. 29 of 222, 13.1%; p ¼ 0.015), and f-QRS (20 of 24, 83.3% vs. 58 of 222, 26.1%; p < 0.001) were observed more often in patients with VF/SCD than in those without VF/SCD. Among the ECG parameters of repolarization abnormalities, a prolonged QTc interval >440 ms (7 of 24, 29.2% vs. 28 of 222, 12.6%; p ¼ 0.036), and inferolateral ER pattern (8 of 24, 33.3% vs. 17 of 222, 7.7%; p < 0.001) were observed more often in patients with VF/SCD than in those without VF/SCD.
Multivariate analysis showed that the following 4 parameters were independent risk factors for arrhythmic events: f-QRS (hazard ratio [HR]: 5.21; 95% confidence interval [CI]: 1.69 to 16.13; p ¼ 0.004), inferolateral ER pattern (HR: 2.87; 95% CI: 1.16 to 7.14; p ¼ 0.023), a history of VF episodes (HR: 19.61; 95% CI: 4.12 to 90.91; p < 0.001), and a history of syncope episodes (HR: 28.57; 95% CI: 6.14 to 142.86; p < 0.001) ( Table 2) .
Patient characteristics with f-QRS. On multivariate analysis, depolarization abnormalities of f-QRS were an independent risk factor for arrhythmic events. Therefore, clinical, genetic, and electrocardiographic data for patients with and without f-QRS were analyzed again ( Table 3 ). There were no significant differences in age, family history of SCD, and incidence of the SCN5A gene mutation between patients with and without f-QRS. However, a history of syncope episodes, a history of VF episodes, and VF inducibility during EP study were more frequently observed in patients with f-QRS than in those without f-QRS (p ¼ 0.002, p ¼ 0.005, and p ¼ 0.002, respectively). PQ interval, QRS duration, and QTc interval were longer in patients with f-QRS than in those without f-QRS (p ¼ 0.037, p ¼ 0.001, and p ¼ 0.042, respectively), but the ER pattern was not different between the groups. Spontaneous type 1 ECG pattern and PAF episodes were more frequently observed in patients with f-QRS than in those without f-QRS (p < 0.001 and p ¼ 0.031, respectively). VF/SCD episodes during follow-up were more frequently observed in patients with f-QRS than in those without f-QRS (p < 0.001). Patient characteristics with an ER pattern. On multivariate analysis, repolarization abnormality of the ER pattern was an independent risk factor for arrhythmic events. Therefore, clinical, genetic, and electrocardiographic data with and without an ER pattern were analyzed again (Table 4 ). There were no significant differences in age, family history of SCD, incidence of SCN5A gene mutation, positive late potential, a history of syncope episodes, f-QRS, and VF inducibility during the EP study. However, VF/ SCD episodes during follow-up and a history of VF episodes were more frequently observed in patients with ER than in those without ER (p ¼ 0.001 and p ¼ 0.005, respectively). Follow-up data. We next examined the follow-up data in patients with f-QRS and ER. VF developed in 23 patients, 1 patient died suddenly during sleep, possibly because of VF, and 1 patient died of a nonarrhythmic cause (pneumonia) during the follow-up period. Figure 2 shows the results of Kaplan-Meier analyses of fatal arrhythmic events in patients with and without f-QRS ( Fig. 2A) or an ER (Fig. 2B) pattern. Patients with f-QRS or ER had a significantly worse prognosis than did patients without those parameters (p < 0.001 and p < 0.001, respectively). Figure 3 shows results of the combination analysis of f-QRS and ER parameters. Patients with both f-QRS and ER parameters had a significantly higher frequency of fatal arrhythmic events than did patients without both parameters (p<0.001). Moreover, patients with both f-QRS and ER parameters had a significantly higher frequency of arrhythmic events than did patients with f-QRS alone (p ¼ 0.045) ( Fig. 3 ).
Discussion
The present study showed that the combination of f-QRS and inferolateral ER pattern was associated with the development of VF in BrS patients. Additionally, the combination of f-QRS with ER (depolarization and repolarization abnormalities) was useful for identifying high-and low-risk BrS patients. High-risk clinical parameters of VF development. Previous studies have reported that syncope episodes (especially in patients with prodrome), a history of VF, and a family history of sudden death are associated with VF events in BrS patients (3, 4, 12, 20, (27) (28) (29) . In our study, we also observed that syncope episodes and a history of VF were independent predictors of later VF events. These patients were symptomatic patients, and therefore, it is reasonable to classify them as high-risk patients. However, more patients have no symptoms with electrocardiographic evidence of BrS (asymptomatic BrS patients). A recent study suggested that these asymptomatic patients have a better prognosis, but this is not negligible (1, 5) . Therefore, simple risk assessment of these asymptomatic BrS patients is clinically important, especially when sporadic cases are detected during routine medical checkups. Repolarization abnormalities in BrS. Many clinical data support the importance of repolarization abnormalities for VF development, such as T-wave alternans after sodium channel blocker injection (16) and ST-segment elevation after exercise (30) or full-stomach status (31) .
An ER pattern is considered to be a benign electrocardiographic phenomenon affecting 2% to 5% of the general population and is most commonly observed in young men (32, 33) . Recently, an ER pattern has been shown to be an additional risk marker for VF development, especially in inferolateral leads, in patients with BrS (17, 18) . Our finding that repolarization abnormalities were independently associated with VF development is in agreement with these previous findings.
Depolarization abnormalities in BrS. In addition to repolarization abnormalities, recent observations have suggested that VF development in BrS is associated with conduction disturbances, such as prolongation of the PQ interval (34), a wide QRS complex (35) , a positive late potential (36) , and f-QRS (15, 20) . A recent study showed that f-QRS is the strongest predictor of VF development in BrS (20) . The usefulness of f-QRS for identifying patients at high risk of various cardiac diseases, including cardiac sarcoidosis, arrhythmogenic right ventricular cardiomyopathy, and acute coronary syndrome (37) , has been reported.
Our finding that f-QRS (depolarization abnormality) was an independent predictor of VF development is in agreement with those results. We also found that f-QRS was associated with other depolarization abnormalities, such as a prolonged PQ and QRS interval, indicating that depolarization abnormalities in the atrium and ventricle are an important factors for the development of VF in BrS. A QRS interval in lead V 2 !120 ms was found to be a possible predictor of life-threatening ventricular arrhythmia and/or syncope. Prolonged QRS duration as measured on a standard 12-lead ECG has been shown to be associated with ventricular arrhythmia (35) . Additionally, a prolonged QRS duration in precordial leads is prominent in symptomatic patients, suggesting that delayed conduction of the ventricle (depolarization) is important (29, 38) . However, on multivariate analysis in our study, there were no significant differences in wide QRS complex between patients with and without VF/SCD. Combination of depolarization and repolarization abnormalities. In this study, Kaplan-Meier analyses showed that the combination of f-QRS (depolarization abnormality) and ER (repolarization abnormality) is useful for predicting VF events in patients with BrS. Recently, f-QRS was reported to be an important marker for the development of VF (Torsades de pointes) in patients with acquired long QT syndrome (typical repolarization abnormality disease) (39) , indicating that the combination of depolarization and repolarization is important for the development of lethal arrhythmia. We also found that VF seldom developed in patients without any abnormalities during the follow-up period in this study, suggesting that low-risk BrS patients could also be identified using these markers.
We also investigated the clinical/electrocardiographic characteristics of depolarization and repolarization abnormalities. Interestingly, there were many differences between the groups (Tables 3 and 4 ). Patients with f-QRS had more depolarization abnormalities than those without f-QRS, such as prolonged PQ and QRS intervals. In contrast, patients with an ER pattern had no differences in these markers, suggesting that the genesis of each of these abnormalities is intrinsically different. Clinical implications. BrS is a heterogeneous disease. Therefore, the mechanism of VF development differs in each patient. Our results suggest that the combination of depolarization and repolarization abnormalities (f-QRS and ER pattern) enables identification of high-and low-risk patients with BrS. In the clinical setting, VF induction during EP study is still considered when deciding to implant an ICD. Thus, we think that we should recommend an EP study in a patient with an f-QRS and ER pattern, if asymptomatic, or we do not need an EP study in an asymptomatic patient with neither an f-QRS nor ER pattern. Study limitations. First, the electrocardiographic features of ER and other electrocardiographic markers are dynamic, and thus the true prevalence of this coexistence is difficult to evaluate. Second, we analyzed only the coding regions of SCN5A for mutations in this study, and the possibility of mutations occurring in regions of the gene other than coding regions or other gene mutations cannot be excluded. Third, Nishii et al. (19) reported that SCN5A gene mutations are associated with early and frequent VF recurrence, but not with initial VF episodes. In our study, we did not find a significant difference. Therefore, further studies on this issue are required. Fourth, this study was a retrospective study. A prospective study to estimate risk factors of BrS is required. Last, there was a small number of endpoints, making it difficult to identify unique predictors in a multivariate model reliably.
Conclusions
Our study shows that ER and f-QRS are independent risk factors for arrhythmic events in patients with BrS. Patients with both ER and f-QRS have a significantly higher frequency of arrhythmic events than do patients who have neither ER nor f-QRS. Furthermore, when there is neither ER nor f-QRS, arrhythmic events are minor.
Clinically, this study shows that the combination of f-QRS (a marker of depolarization abnormality) and ER (a marker of repolarization abnormality) is useful for estimating the incidence of VF in patients with BrS.
